Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07285863 · ClinicalTrials.gov registry record · Phase 4
A Study Of Effect Of Secretin For In Injection (Chirostim) On Pancreatic Fluid Composition In Healthy Subjects
A Phase 4 study, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 24
- Enrollment target
NCT07285863: Recruiting Phase 4 study, sponsored by Mayo Clinic.
NCT07285863 is a Phase 4 study that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 24 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07285863, a Phase 4 study, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 24 participants
- Enrollment target
Study Summary
The purpose of this study is to collect pancreas fluid from the duodenum using the endoscopic pancreas function collection method in healthy participants after pancreatic stimulation with human secretin.
Primary Outcome
A primary outcome will be the bicarbonate level (milliequivalent per liter) in the pancreatic fluid collected.
Interventions
- DRUG Secretin (human synthetic) - ChiRhoClin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2026-03-11 |
| Est. Completion | 2028-03 |
| Phase | Phase 4 |
What NCT07285863 shows while recruiting
NCT07285863 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 1 intervention - of which Secretin (human synthetic) - ChiRhoClin is the first listed.
NCT07285863 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07285863 about?
NCT07285863 is a clinical study titled "A Study Of Effect Of Secretin For In Injection (Chirostim) On Pancreatic Fluid Composition In Healthy Subjects". The purpose of this study is to collect pancreas fluid from the duodenum using the endoscopic pancreas function collection method in healthy participants after pancreatic stimulation with human secretin.
What is the current status of trial NCT07285863?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 24 participants. The study started on 2026-03-11. Estimated completion is 2028-03.
What interventions are being tested in trial NCT07285863?
The interventions under investigation include: Secretin (human synthetic) - ChiRhoClin (DRUG).
Who is sponsoring clinical trial NCT07285863?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07285863's enrollment target sits among peer trials
24 1699th of 2000 higher than 276 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI